Zhang Y, Gripenberg-Lerche C, Söderström K O, Toivanen A, Toivanen P
Department of Medical Microbiology, Turku University, Finland.
Arthritis Rheum. 1996 Jul;39(7):1238-43. doi: 10.1002/art.1780390725.
To study the effect of antibiotic prophylaxis and treatment of reactive arthritis (ReA), using an experimental model.
Yersinia enterocolitica O:8, when injected intravenously into Lewis rats, causes a sterile arthritis closely resembling human ReA in 70% of the animals. Arthritis develops in 1-2 weeks; in some of the animals it remains chronic, and exacerbations occur. This model was applied to study the effect of a 7-day treatment with ciprofloxacin, using 2 different dosages (20 or 100 mg/kg/day) and 4 different schedules for initiation of treatment. The effects were evaluated by determining the daily arthritis score, the number of rats developing arthritis, and fecal excretion of Yersinia. In addition, weight gain was monitored. At autopsy (35 or 60 days after inoculation with bacteria), samples were obtained for determination of Yersinia-specific antibodies in the serum. At the same time, samples were collected from mesenteric lymph nodes, lung, spleen, and liver for bacterial cultures, and from the ankle joints for histologic evaluation. In a separate experiment, ciprofloxacin concentrations in samples from serum and mesenteric lymph nodes were analyzed by high performance liquid chromatography.
A 7-day course with 100 mg/kg/day of ciprofloxacin, started on day 3 after bacterial inoculation, completely prevented the development of ReA and eliminated Yersinia during the 60-day experiment. If a dosage of 20 mg/kg/day was used, development of acute arthritis was prevented, but some of the animals had positive fecal cultures at the end of experiment. If antibiotic treatment was started on day 5, the preventive effect was still observed, but was less pronounced. If the treatment was started at the peak of the development of arthritis, no effect on arthritis was observed.
These results indicate that if any effect of antibiotic treatment in Yersinia-triggered ReA is to be expected, the treatment must be started early and given in sufficient dosage. However, antibiotic treatment has no effect on fully developed arthritis.
利用实验模型研究抗生素预防和治疗反应性关节炎(ReA)的效果。
将小肠结肠炎耶尔森菌O:8静脉注射到Lewis大鼠体内时,70%的动物会出现与人类ReA极为相似的无菌性关节炎。关节炎在1至2周内发展;在一些动物中,关节炎会持续存在并反复发作。该模型用于研究环丙沙星7天治疗的效果,使用2种不同剂量(20或100毫克/千克/天)和4种不同的治疗开始时间表。通过确定每日关节炎评分、患关节炎大鼠的数量以及耶尔森菌的粪便排泄量来评估效果。此外,监测体重增加情况。在尸检时(接种细菌后35或60天),采集样本以测定血清中的耶尔森菌特异性抗体。同时,从肠系膜淋巴结、肺、脾和肝脏采集样本进行细菌培养,并从踝关节采集样本进行组织学评估。在另一个实验中,通过高效液相色谱法分析血清和肠系膜淋巴结样本中的环丙沙星浓度。
在细菌接种后第3天开始,使用100毫克/千克/天的环丙沙星进行7天疗程,在60天的实验中完全预防了ReA的发展并清除了耶尔森菌。如果使用20毫克/千克/天的剂量,可预防急性关节炎的发展,但在实验结束时,一些动物的粪便培养结果仍为阳性。如果在第5天开始抗生素治疗,仍可观察到预防效果,但不太明显。如果在关节炎发展的高峰期开始治疗,则未观察到对关节炎的影响。
这些结果表明,如果期望抗生素治疗对耶尔森菌引发的ReA有任何效果,治疗必须尽早开始并给予足够的剂量。然而,抗生素治疗对完全发展的关节炎没有效果。